CHM
Basic information
Region (hg38): X:85861180-86047561
Previous symbols: [ "TCD", "DXS540" ]
Links
Phenotypes
GenCC
Source:
- choroideremia (Definitive), mode of inheritance: XL
- choroideremia (Definitive), mode of inheritance: XLR
- choroideremia (Strong), mode of inheritance: XL
- choroideremia (Supportive), mode of inheritance: XL
- choroideremia (Definitive), mode of inheritance: XL
- choroideremia (Definitive), mode of inheritance: XL
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Choiroideremia | XL | General | Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing | Ophthalmologic | 2886237; 1302003; 1598901; 8477262; 7981671; 12827496; 19764077; 20301511; 22965595; 24913019 |
ClinVar
This is a list of variants' phenotypes submitted to
- not provided (179 variants)
- Choroideremia (37 variants)
- Retinal dystrophy (12 variants)
- CHM-related disorder (3 variants)
- Retinitis pigmentosa (2 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the CHM gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 180 | 18 | 201 | |||
missense | 140 | 19 | 11 | 174 | ||
nonsense | 71 | 13 | 85 | |||
start loss | 3 | |||||
frameshift | 81 | 18 | 99 | |||
inframe indel | 4 | |||||
splice donor/acceptor (+/-2bp) | 37 | 13 | 51 | |||
splice region | 1 | 3 | 6 | 36 | 7 | 53 |
non coding | 77 | 42 | 123 | |||
Total | 193 | 49 | 150 | 276 | 72 |
Highest pathogenic variant AF is 0.0000152
Variants in CHM
This is a list of pathogenic ClinVar variants found in the CHM region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
X-85864632-A-G | Choroideremia | Uncertain significance (Jun 01, 2022) | ||
X-85864638-A-C | Uncertain significance (Jan 04, 2022) | |||
X-85864642-C-T | Likely benign (Mar 03, 2023) | |||
X-85864643-TC-GA | Uncertain significance (May 11, 2022) | |||
X-85864647-C-T | Uncertain significance (Jun 13, 2022) | |||
X-85864658-A-AGGTTTGTGCTTT | Benign (Jan 11, 2024) | |||
X-85864663-T-G | Choroideremia | Benign (Nov 17, 2023) | ||
X-85864672-C-T | Choroideremia | Likely benign (Aug 28, 2023) | ||
X-85864674-T-C | Uncertain significance (Feb 04, 2022) | |||
X-85864684-C-A | Likely benign (May 20, 2023) | |||
X-85864684-C-T | Likely benign (Jan 11, 2024) | |||
X-85864685-G-A | Uncertain significance (Aug 30, 2021) | |||
X-85864687-G-T | Inborn genetic diseases | Uncertain significance (Apr 06, 2024) | ||
X-85864690-A-G | Likely benign (Apr 28, 2023) | |||
X-85864699-T-C | Choroideremia | Uncertain significance (Aug 28, 2021) | ||
X-85864702-G-A | Likely benign (Jul 08, 2021) | |||
X-85864713-C-T | Uncertain significance (May 10, 2022) | |||
X-85864726-C-T | Likely benign (Jan 27, 2023) | |||
X-85864727-T-C | Uncertain significance (May 05, 2022) | |||
X-85864728-G-A | Uncertain significance (Aug 04, 2023) | |||
X-85864735-G-T | Likely benign (Nov 18, 2023) | |||
X-85864738-T-C | Likely benign (Aug 10, 2022) | |||
X-85864759-A-G | Benign (Jan 25, 2024) | |||
X-85864764-T-C | Inborn genetic diseases | Uncertain significance (Feb 10, 2023) | ||
X-85864765-T-C | Likely benign (Mar 17, 2023) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
CHM | protein_coding | protein_coding | ENST00000357749 | 15 | 186382 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.999 | 0.00101 | 125140 | 1 | 1 | 125142 | 0.00000799 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.793 | 195 | 229 | 0.852 | 0.0000161 | 4300 |
Missense in Polyphen | 71 | 91.524 | 0.77576 | 1819 | ||
Synonymous | -1.20 | 95 | 81.3 | 1.17 | 0.00000585 | 1195 |
Loss of Function | 4.39 | 1 | 24.4 | 0.0410 | 0.00000189 | 446 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.0000366 | 0.0000366 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.00 | 0.00 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.00 | 0.00 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.0000599 | 0.0000328 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Substrate-binding subunit of the Rab geranylgeranyltransferase (GGTase) complex. Binds unprenylated Rab proteins and presents the substrate peptide to the catalytic component B composed of RABGGTA and RABGGTB, and remains bound to it after the geranylgeranyl transfer reaction. The component A is thought to be regenerated by transferring its prenylated Rab back to the donor membrane. Besides, a pre-formed complex consisting of CHM and the Rab GGTase dimer (RGGT or component B) can bind to and prenylate Rab proteins; this alternative pathway is proposed to be the predominant pathway for Rab protein geranylgeranylation. {ECO:0000269|PubMed:18532927, ECO:0000269|PubMed:7957092}.;
- Disease
- DISEASE: Choroideremia (CHM) [MIM:303100]: An X-linked recessive disease characterized by a slowly progressive degeneration of the choroid, photoreceptors, and retinal pigment epithelium. Affected males develop night blindness in their teenage years followed by loss of peripheral vision and complete blindness at middle age. Carrier females are generally asymptomatic but funduscopic examination often shows patchy areas of chorioretinal atrophy. {ECO:0000269|PubMed:19427510, ECO:0000269|PubMed:21905166, ECO:0000269|PubMed:7951216}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
- Pathway
- Gene expression (Transcription);Vesicle-mediated transport;Membrane Trafficking;Generic Transcription Pathway;Post-translational protein modification;Metabolism of proteins;TP53 Regulates Transcription of Cell Death Genes;RNA Polymerase II Transcription;TP53 regulates transcription of several additional cell death genes whose specific roles in p53-dependent apoptosis remain uncertain;Rab regulation of trafficking;Transcriptional Regulation by TP53;RAB GEFs exchange GTP for GDP on RABs;RAB geranylgeranylation
(Consensus)
Recessive Scores
- pRec
- 0.245
Intolerance Scores
- loftool
- rvis_EVS
- 0.17
- rvis_percentile_EVS
- 65.96
Haploinsufficiency Scores
- pHI
- 0.133
- hipred
- Y
- hipred_score
- 0.633
- ghis
- 0.599
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.0770
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Chm
- Phenotype
- growth/size/body region phenotype; homeostasis/metabolism phenotype; embryo phenotype; cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); normal phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); pigmentation phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); vision/eye phenotype;
Zebrafish Information Network
- Gene name
- chm
- Affected structure
- neuromast hair cell
- Phenotype tag
- abnormal
- Phenotype quality
- decreased amount
Gene ontology
- Biological process
- protein targeting to membrane;small GTPase mediated signal transduction;visual perception;protein geranylgeranylation;regulation of apoptotic process;positive regulation of GTPase activity;post-translational protein modification
- Cellular component
- cytosol;Rab-protein geranylgeranyltransferase complex
- Molecular function
- Rab geranylgeranyltransferase activity;GDP-dissociation inhibitor activity;GTPase activator activity;Rab GTPase binding